Biotechnology
Compare Stocks
4 / 10Stock Comparison
BTX vs GSBD vs ARCC vs GBDC
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
BTX vs GSBD vs ARCC vs GBDC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Biotechnology | Asset Management | Asset Management | Asset Management |
| Market Cap | $951M | $1.04B | $13.65B | $3.43B |
| Revenue (TTM) | $41M | $242M | $3.15B | $871M |
| Net Income (TTM) | $36M | $112M | $1.15B | $205M |
| Gross Margin | 100.0% | 75.4% | 75.7% | 81.5% |
| Operating Margin | 87.7% | 98.4% | 69.7% | 78.9% |
| Forward P/E | 47.9x | 7.5x | 9.9x | 9.5x |
| Total Debt | $0.00 | $1.88B | $15.99B | $4.90B |
| Cash & Equiv. | — | $43M | $924M | $24M |
BTX vs GSBD vs ARCC vs GBDC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| BlackRock Technolog… (BTX) | 100 | 40.1 | -59.9% |
| Goldman Sachs BDC, … (GSBD) | 100 | 48.0 | -52.0% |
| Ares Capital Corpor… (ARCC) | 100 | 101.6 | +1.6% |
| Golub Capital BDC, … (GBDC) | 100 | 90.0 | -10.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BTX vs GSBD vs ARCC vs GBDC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BTX is the #2 pick in this set and the best alternative if quality and momentum is your priority.
- 87.7% margin vs ARCC's 41.3%
- +35.3% vs ARCC's -0.3%
GSBD carries the broadest edge in this set and is the clearest fit for income & stability and bank quality.
- Dividend streak 1 yrs, beta 0.46, yield 21.8%
- NIM 7.4% vs ARCC's 3.6%
- Lower P/E (7.5x vs 9.9x)
- Beta 0.46 vs BTX's 1.28
ARCC is the clearest fit if your priority is long-term compounding.
- 139.6% 10Y total return vs GBDC's 61.1%
- 3.8% ROA vs BTX's 1.8%, ROIC 5.7% vs 1.4%
GBDC is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 42.5%, EPS growth 4.4%
- Lower volatility, beta 0.61, current ratio 5.35x
- PEG 0.31 vs ARCC's 0.97
- Beta 0.61, yield 10.5%, current ratio 5.35x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 42.5% NII/revenue growth vs BTX's -81.1% | |
| Value | Lower P/E (7.5x vs 9.9x) | |
| Quality / Margins | 87.7% margin vs ARCC's 41.3% | |
| Stability / Safety | Beta 0.46 vs BTX's 1.28 | |
| Dividends | 21.8% yield, 1-year raise streak, vs GBDC's 10.5% | |
| Momentum (1Y) | +35.3% vs ARCC's -0.3% | |
| Efficiency (ROA) | 3.8% ROA vs BTX's 1.8%, ROIC 5.7% vs 1.4% |
BTX vs GSBD vs ARCC vs GBDC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BTX leads in 2 of 6 categories
GSBD leads 2 • ARCC leads 0 • GBDC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BTX leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARCC is the larger business by revenue, generating $3.1B annually — 77.3x BTX's $41M. BTX is the more profitable business, keeping 87.7% of every revenue dollar as net income compared to ARCC's 41.3%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $41M | $242M | $3.1B | $871M |
| EBITDAEarnings before interest/tax | — | $191M | $2.0B | $431M |
| Net IncomeAfter-tax profit | — | $112M | $1.1B | $205M |
| Free Cash FlowCash after capex | — | $202M | $1.1B | $313M |
| Gross MarginGross profit ÷ Revenue | +100.0% | +75.4% | +75.7% | +81.5% |
| Operating MarginEBIT ÷ Revenue | +87.7% | +98.4% | +69.7% | +78.9% |
| Net MarginNet income ÷ Revenue | +87.7% | +49.2% | +41.3% | +43.2% |
| FCF MarginFCF ÷ Revenue | +6.8% | +134.3% | +36.3% | -13.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | -144.4% | -63.9% | -160.0% |
Valuation Metrics
GSBD leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 9.0x trailing earnings, GSBD trades at a 81% valuation discount to BTX's 47.9x P/E. Adjusting for growth (PEG ratio), GBDC offers better value at 0.30x vs ARCC's 0.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $951M | $1.0B | $13.6B | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $951M | $2.9B | $28.7B | $8.3B |
| Trailing P/EPrice ÷ TTM EPS | 47.94x | 9.01x | 10.22x | 9.27x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.52x | 9.94x | 9.53x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.99x | 0.30x |
| EV / EBITDAEnterprise value multiple | 26.64x | 12.26x | 13.11x | 12.08x |
| Price / SalesMarket cap ÷ Revenue | 23.38x | 4.31x | 4.34x | 3.94x |
| Price / BookPrice ÷ Book value/share | 0.99x | 0.75x | 0.93x | 0.88x |
| Price / FCFMarket cap ÷ FCF | 3.43x | 3.21x | 11.95x | — |
Profitability & Efficiency
Evenly matched — BTX and ARCC each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
ARCC delivers a 8.1% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $2 for BTX. ARCC carries lower financial leverage with a 1.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to GSBD's 1.32x. On the Piotroski fundamental quality scale (0–9), GSBD scores 6/9 vs BTX's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.9% | +7.8% | +8.1% | +5.2% |
| ROA (TTM)Return on assets | +1.8% | +3.3% | +3.8% | +2.3% |
| ROICReturn on invested capital | +1.4% | +5.3% | +5.7% | +5.9% |
| ROCEReturn on capital employed | +1.8% | +7.0% | +7.5% | +7.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 4 | 4 |
| Debt / EquityFinancial leverage | — | 1.32x | 1.12x | 1.23x |
| Net DebtTotal debt minus cash | $0 | $1.8B | $15.1B | $4.9B |
| Cash & Equiv.Liquid assets | — | $43M | $924M | $24M |
| Total DebtShort + long-term debt | $0 | $1.9B | $16.0B | $4.9B |
| Interest CoverageEBIT ÷ Interest expense | 2313.25x | 1.28x | 2.98x | 1.62x |
Total Returns (Dividends Reinvested)
BTX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARCC five years ago would be worth $14,799 today (with dividends reinvested), compared to $6,282 for BTX. Over the past 12 months, BTX leads with a +35.3% total return vs ARCC's -0.3%. The 3-year compound annual growth rate (CAGR) favors BTX at 13.0% vs GSBD's 3.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +25.0% | +3.8% | -4.6% | -0.6% |
| 1-Year ReturnPast 12 months | +35.3% | +3.8% | -0.3% | +2.0% |
| 3-Year ReturnCumulative with dividends | +44.2% | +12.2% | +34.5% | +35.4% |
| 5-Year ReturnCumulative with dividends | -37.2% | -6.8% | +48.0% | +33.9% |
| 10-Year ReturnCumulative with dividends | -37.3% | +41.3% | +139.6% | +61.1% |
| CAGR (3Y)Annualised 3-year return | +13.0% | +3.9% | +10.4% | +10.6% |
Risk & Volatility
Evenly matched — BTX and GSBD each lead in 1 of 2 comparable metrics.
Risk & Volatility
GSBD is the less volatile stock with a 0.46 beta — it tends to amplify market swings less than BTX's 1.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BTX currently trades 99.1% from its 52-week high vs GSBD's 77.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.28x | 0.46x | 0.75x | 0.61x |
| 52-Week HighHighest price in past year | $8.22 | $12.03 | $23.42 | $15.63 |
| 52-Week LowLowest price in past year | $6.13 | $8.66 | $17.40 | $11.77 |
| % of 52W HighCurrent price vs 52-week peak | +99.1% | +77.1% | +81.2% | +84.2% |
| RSI (14)Momentum oscillator 0–100 | 69.4 | 59.6 | 52.9 | 49.1 |
| Avg Volume (50D)Average daily shares traded | 730K | 1.4M | 7.4M | 2.3M |
Analyst Outlook
GSBD leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GSBD as "Hold", ARCC as "Buy", GBDC as "Buy". Consensus price targets imply 15.1% upside for ARCC (target: $22) vs -3.0% for GSBD (target: $9). For income investors, GSBD offers the higher dividend yield at 21.77% vs ARCC's 2.02%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $9.00 | $21.88 | $14.25 |
| # AnalystsCovering analysts | — | 9 | 32 | 11 |
| Dividend YieldAnnual dividend ÷ price | +10.5% | +21.8% | +2.0% | +10.5% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.86 | $2.02 | $0.38 | $1.38 |
| Buyback YieldShare repurchases ÷ mkt cap | +9.7% | +5.0% | 0.0% | +2.3% |
BTX leads in 2 of 6 categories (Income & Cash Flow, Total Returns). GSBD leads in 2 (Valuation Metrics, Analyst Outlook). 2 tied.
BTX vs GSBD vs ARCC vs GBDC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BTX or GSBD or ARCC or GBDC a better buy right now?
For growth investors, Golub Capital BDC, Inc.
(GBDC) is the stronger pick with 42. 5% revenue growth year-over-year, versus -81. 1% for BlackRock Technology and Private Equity Term Trust (BTX). Goldman Sachs BDC, Inc. (GSBD) offers the better valuation at 9. 0x trailing P/E (7. 5x forward), making it the more compelling value choice. Analysts rate Ares Capital Corporation (ARCC) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BTX or GSBD or ARCC or GBDC?
On trailing P/E, Goldman Sachs BDC, Inc.
(GSBD) is the cheapest at 9. 0x versus BlackRock Technology and Private Equity Term Trust at 47. 9x. On forward P/E, Goldman Sachs BDC, Inc. is actually cheaper at 7. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Golub Capital BDC, Inc. wins at 0. 31x versus Ares Capital Corporation's 0. 97x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BTX or GSBD or ARCC or GBDC?
Over the past 5 years, Ares Capital Corporation (ARCC) delivered a total return of +48.
0%, compared to -37. 2% for BlackRock Technology and Private Equity Term Trust (BTX). Over 10 years, the gap is even starker: ARCC returned +139. 6% versus BTX's -37. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BTX or GSBD or ARCC or GBDC?
By beta (market sensitivity over 5 years), Goldman Sachs BDC, Inc.
(GSBD) is the lower-risk stock at 0. 46β versus BlackRock Technology and Private Equity Term Trust's 1. 28β — meaning BTX is approximately 178% more volatile than GSBD relative to the S&P 500. On balance sheet safety, Ares Capital Corporation (ARCC) carries a lower debt/equity ratio of 112% versus 132% for Goldman Sachs BDC, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BTX or GSBD or ARCC or GBDC?
By revenue growth (latest reported year), Golub Capital BDC, Inc.
(GBDC) is pulling ahead at 42. 5% versus -81. 1% for BlackRock Technology and Private Equity Term Trust (BTX). On earnings-per-share growth, the picture is similar: Goldman Sachs BDC, Inc. grew EPS 87. 3% year-over-year, compared to -82. 7% for BlackRock Technology and Private Equity Term Trust. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BTX or GSBD or ARCC or GBDC?
BlackRock Technology and Private Equity Term Trust (BTX) is the more profitable company, earning 87.
7% net margin versus 41. 3% for Ares Capital Corporation — meaning it keeps 87. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GSBD leads at 98. 4% versus 69. 7% for ARCC. At the gross margin level — before operating expenses — BTX leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BTX or GSBD or ARCC or GBDC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Golub Capital BDC, Inc. (GBDC) is the more undervalued stock at a PEG of 0. 31x versus Ares Capital Corporation's 0. 97x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Goldman Sachs BDC, Inc. (GSBD) trades at 7. 5x forward P/E versus 9. 9x for Ares Capital Corporation — 2. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARCC: 15. 1% to $21. 88.
08Which pays a better dividend — BTX or GSBD or ARCC or GBDC?
All stocks in this comparison pay dividends.
Goldman Sachs BDC, Inc. (GSBD) offers the highest yield at 21. 8%, versus 2. 0% for Ares Capital Corporation (ARCC).
09Is BTX or GSBD or ARCC or GBDC better for a retirement portfolio?
For long-horizon retirement investors, Goldman Sachs BDC, Inc.
(GSBD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 46), 21. 8% yield). Both have compounded well over 10 years (GSBD: +41. 3%, BTX: -37. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BTX and GSBD and ARCC and GBDC?
These companies operate in different sectors (BTX (Healthcare) and GSBD (Financial Services) and ARCC (Financial Services) and GBDC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BTX is a small-cap income-oriented stock; GSBD is a small-cap high-growth stock; ARCC is a mid-cap high-growth stock; GBDC is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.